Activation of the High Mobility Group Box 1/Receptor for Advanced Glycation Endproducts /NOD‐like Receptor Family Pyrin Domain‐Containing 3 Axis Under Chronic Intermittent Hypoxia Induction Promotes the Progression of Atherosclerosis in ApoE−/− Mice

Activation of the High Mobility Group Box 1/Receptor for Advanced Glycation Endproducts /NOD‐like Receptor Family Pyrin Domain‐Containing 3 Axis Under Chronic Intermittent Hypoxia Induction Promotes the Progression of Atherosclerosis in ApoE−/− Mice

Background Chronic intermittent hypoxia (CIH) has been regarded as an important cause of atherosclerotic disease. In our study, we set out to investigate whether CIH regulated the high mobility group box 1/receptor for advanced glycation endproducts/NOD‐like receptor family pyrin domain‐containing 3...

Full description

Bibliographic Details
Main Authors:	Haoqu Tan, Jinfang Hu, Wei Zuo, Yun Huang, Jian Cui, Fei Gong, Wei Bai
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	atherosclerosis chronic intermittent hypoxia HMGB1 NLRP3 promoter methylation RAGE
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.121.024397

Similar Items

The receptor for advanced glycation endproducts (RAGE) does not contribute to pathology in a mouse mesenteric ischemia/reperfusion-induced injury model
by: Mike C.L. Wu, et al.
Published: (2015-12-01)

Strategies for PET imaging of the receptor for advanced glycation endproducts (RAGE)
by: Lindsey R. Drake, et al.
Published: (2020-10-01)

High-mobility group box 1 protein, receptor for advanced glycation end products and nucleosomes increases after marathon
by: Julia Schoenfeld, et al.
Published: (2023-02-01)

The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice
by: Toni Weinhage, et al.
Published: (2020-06-01)

Pseudomonas aeruginosa significantly increases expression of receptor for advanced glycation endproducts (RAGE) in the septicemia suffering patients
by: A. Kariminik, et al.
Published: (2021-11-01)

Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer
by: Sakshi Taneja, et al.
Published: (2021-07-01)

Inhibition of Homophilic Interactions and Ligand Binding of the Receptor for Advanced Glycation End Products by Heparin and Heparin-Related Carbohydrate Structures
by: Ari Rouhiainen, et al.
Published: (2018-07-01)

Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression
by: Agnieszka Bronowicka-Szydełko, et al.
Published: (2021-09-01)

HMGB1/RAGE axis in tumor development: unraveling its significance
by: Anqi Fan, et al.
Published: (2024-03-01)

Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis
by: Judyta eJuranek, et al.
Published: (2015-12-01)

Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
by: Lingzhao Li, et al.
Published: (2022-07-01)

Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases
by: Vanesa Cepas, et al.
Published: (2020-02-01)

Contributing Role of High Mobility Group Box 1 Signaling in Oral Cancer Development and Therapy
by: Grigorios Plemmenos, et al.
Published: (2023-07-01)

Detection of receptor for advanced glycation end products (RAGE) and high mobility group protein box 1 HMGB1 levels in patients’ serum with breast cancer
by: Hind Shawqi Zaki, et al.
Published: (2023-01-01)

Dysbiosis-Related Advanced Glycation Endproducts and Trimethylamine N-Oxide in Chronic Kidney Disease
by: Kensei Taguchi, et al.
Published: (2021-05-01)

Advanced glycation endproducts mediate chronic kidney injury with characteristic patterns in different stages
by: Xiaoxia Huang, et al.
Published: (2022-09-01)

HMGB1 Increases IL-1β Production in Vascular Smooth Muscle Cells via NLRP3 Inflammasome
by: Eun Jung Kim, et al.
Published: (2018-03-01)

Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
by: Huan Yang, et al.
Published: (2019-04-01)

Role and Mechanisms of RAGE-Ligand Complexes and RAGE-Inhibitors in Cancer Progression
by: Ali H. El-Far, et al.
Published: (2020-05-01)

Pathophysiological Implication of Pattern Recognition Receptors in Fetal Membranes Rupture: RAGE and NLRP Inflammasome
by: Helena Choltus, et al.
Published: (2021-08-01)

The time course of nod-like receptor family pyrin domain containing 3 inflammasome complex expressions in the testis tissue of an experimental varicocele rat model: An experimental study
by: Hamideh Fallah Asl, et al.
Published: (2023-08-01)

Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
by: Harbinder Singh, et al.
Published: (2022-10-01)

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
by: Hiromi Abe, et al.
Published: (2023-09-01)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
by: Lara Caldiroli, et al.
Published: (2022-06-01)

A Potential Role for the Receptor for Advanced Glycation End-Products (RAGE) in the Development of Secondhand Smoke-Induced Chronic Sinusitis
by: Hannah Robin, et al.
Published: (2024-01-01)

RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma
by: Jaisy Arikkatt, et al.
Published: (2017-01-01)

HMGB1 in inflammation and cancer
by: Shumin Wang, et al.
Published: (2020-08-01)

Myelin basic protein charge isomers change macrophage polarization
by: Tsitsilashvili E, et al.
Published: (2019-01-01)

Increased dermal expression of chromatin-associated protein HMGB1 and concomitant T-cell expression of the DNA RAGE in patients with psoriasis vulgaris
by: Strohbuecker L, et al.
Published: (2019-02-01)

Antenatal Secondhand Smoke (SHS) Exposure and the Receptor for Advanced Glycation End-Products (RAGE)
by: Katrina L. Curtis, et al.
Published: (2024-01-01)

Helicobacter pylori activates HMGB1 expression and recruits RAGE into lipid rafts to promote inflammation in gastric epithelial cells
by: Hwai-Jeng Lin, et al.
Published: (2016-09-01)

Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis
by: Weijian Mai, et al.
Published: (2020-03-01)

Genotype–phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients
by: Priyatharsan Yoganathan, et al.
Published: (2021-08-01)

Vitamin D Status Modestly Regulates NOD-Like Receptor Family with a Pyrin Domain 3 Inflammasome and Interleukin Profiles among Arab Adults
by: Sobhy M. Yakout, et al.
Published: (2023-11-01)

Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic Tumors
by: Priyanka Swami, et al.
Published: (2021-04-01)

Satellite Cell Expression of RAGE (Receptor for Advanced Glycation end Products) Is Important for Collateral Vessel Formation
by: Laura Hansen, et al.
Published: (2021-11-01)

No Glycation Required: Interference of Casein in AGE Receptor Binding Tests
by: Hannah E. Zenker, et al.
Published: (2021-08-01)

Advanced glycation end products regulate the receptor of AGEs epigenetically
by: Xiaoqing Wu, et al.
Published: (2023-02-01)

The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling.
by: James C Reed, et al.
Published: (2020-01-01)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality
by: Adeline Lim, et al.
Published: (2021-03-01)